EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Relevance of FOXP3, PD-L1, PD-1, and miR-155 Gene Expression and Genetic Variants in HPV-Negative Oral Carcinomas

Nemanja Ivkovic iD, Debora Misic iD, Ruzica Kozomara, Sasa Jovic iD, Ahmad Sami iD, Gordana Velikic iD, Srboljub Stosic, Gordana Supic iD

International Journal of Molecular Sciences · 25.07.2025 · 26 (15) · 7218

DOI: 10.3390/ijms26157218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.07.2025. Verfasst von Nemanja Ivkovic und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medical Research, Military Medical Academy, 11040 Belgrade, Serbia. Hauptthemen laut MEDLINE: Forkhead Transcription Factors, MicroRNAs, Mouth Neoplasms, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Faculty of Military Medical Academy, University of Defense, Belgrade, Serbia, University of Defense, Belgrade, Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PD-L1, PD-1, FOXP3, and miR-155 are emerging as key modulators of immune evasion and progression of oral squamous cell carcinoma (OSCC). This study investigated the clinical relevance of their gene expression and variants in HPV-negative OSCC. Bulk-tissue mRNA expression was evaluated in 70 patients, while variants in PD-1 (rs36084323), PD-L1 (rs822336, rs4143815, copy number variation), FOXP3 (rs3761548, rs2232365), and miR-155 (rs767649) were assessed in 134 patients. Expression data were validated using the TCGA cohort of 222 HPV-negative OSCC cases. Low FOXP3 expression was significantly associated with tumor stage (MMA: p = 0.028, TCGA: p = 0.025) and poor overall survival (MMA: p = 0.0004, TCGA: p = 0.019) in both cohorts. Declining FOXP3 expression correlated with advancing tumor stages, and low FOXP3 expression was significantly associated with poor survival in advanced stage III–IV tumors (MMA: p = 0.001, TCGA: p = 0.015), but not early-stage tumors. High miR-155 expression was associated with recurrence (p = 0.002) and poor survival in the MMA (p = 0.007), but not TCGA cohort. MiR-155 rs767649 was associated with alcohol consumption (p = 0.018). These findings point to FOXP3 and miR-155 as potential prognostic biomarkers for HPV-negative OSCC. Stage-specific FOXP3 expression suggests a dynamic immunoregulatory role, with implications for optimizing immunotherapy timing. Further studies are warranted to resolve cellular context and stage-adapted immune interventions in HPV-negative OSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Forkhead Transcription FactorsMicroRNAsMouth NeoplasmsProgrammed Cell Death 1 ReceptorB7-H1 AntigenCarcinoma, Squamous CellHumansFemaleMaleMiddle AgedGene Expression Regulation, NeoplasticAgedAdultBiomarkers, TumorPolymorphism, Single NucleotidePrognosisClinical Relevance

Stichwörter der Autor:innen

FOXP3OSCCPD-1PD-L1gene expressiongenetic variantsmiR-155oral cancerrecurrencesurvival

Substanzen

Forkhead Transcription FactorsFOXP3 protein, humanMicroRNAsMIRN155 microRNA, humanProgrammed Cell Death 1 ReceptorB7-H1 AntigenCD274 protein, humanPDCD1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Institute for Medical Research, Military Medical Academy, 11040 Belgrade, Serbia.
  • Medical Faculty of Military Medical Academy, University of Defense, 11000 Belgrade, Serbia.
  • Clinic for Maxillofacial Surgery, Military Medical Academy, 11040 Belgrade, Serbia.
  • Cellular and Molecular Radiation Oncology Laboratory, Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, 69120 Mannheim, Germany.
  • Hajim School of Engineering, University of Rochester, Rochester, NY 14627, USA.

ORCID-Profile: Nemanja Ivkovic, Debora Misic, Sasa Jovic, Ahmad Sami, Gordana Velikic, Gordana Supic

Förderung

  • Medical Faculty of Military Medical Academy, University of Defense, Belgrade, Serbia
  • University of Defense, Belgrade, Serbia

Zitieren

APA

Ivkovic, N., Misic, D., Kozomara, R., Jovic, S., Sami, A., Velikic, G., Stosic, S., & Supic, G. (2025). Clinical Relevance of FOXP3, PD-L1, PD-1, and miR-155 Gene Expression and Genetic Variants in HPV-Negative Oral Carcinomas. International Journal of Molecular Sciences, 26(15), 7218. https://doi.org/10.3390/ijms26157218

Vancouver

Ivkovic N, Misic D, Kozomara R, Jovic S, Sami A, Velikic G, et al. Clinical Relevance of FOXP3, PD-L1, PD-1, and miR-155 Gene Expression and Genetic Variants in HPV-Negative Oral Carcinomas. International Journal of Molecular Sciences. 2025;26(15):7218. doi:10.3390/ijms26157218

BibTeX
@article{Ivkovic2025,
  author = {Ivkovic, Nemanja and Misic, Debora and Kozomara, Ruzica and Jovic, Sasa and Sami, Ahmad and Velikic, Gordana and Stosic, Srboljub and Supic, Gordana},
  title = {Clinical Relevance of FOXP3, PD-L1, PD-1, and miR-155 Gene Expression and Genetic Variants in HPV-Negative Oral Carcinomas},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {15},
  pages = {7218},
  doi = {10.3390/ijms26157218}
}
Kostenlos starten →